Acetylcholine release from the midbrain interpeduncular nucleus during anesthesia

K Taguchi1, M J Andresen, I D Hentall

  • 1Department of Biomedical Sciences, University of Illinois College of Medicine, Rockford 61107-1897.

Neuroreport
|December 1, 1991
PubMed

Insights

General anesthesia increases acetylcholine (ACh) in the interpeduncular nucleus (IPN). This study found diverse anesthetics enhance IPN output, a key brain region for metabolic regulation.

Area of Science:

  • Neuroscience
  • Anesthesiology
  • Pharmacology

Background:

  • A previous study noted a significant local rise in metabolism within the interpeduncular nucleus (IPN) during general anesthesia.
  • The IPN is a highly cholinoceptive region located in the ventral midbrain.

Purpose of the Study:

  • To investigate the functional correlate of increased metabolism in the IPN during anesthesia.
  • To measure interstitial acetylcholine (ACh) levels in the IPN under different anesthetic conditions.

Main Methods:

  • Utilized chronically implanted microdialysis probes in rats to measure interstitial ACh.
  • Administered anesthetics via inhalation (halothane) and intraperitoneal injection (ketamine, pentobarbital).
  • Mapped brainstem regions under anesthesia to identify the source of ACh.

Main Results:

  • Inhalation of halothane significantly increased interstitial ACh in the IPN (1425% of baseline).
  • Intraperitoneal injection of ketamine also elevated IPN ACh levels (387% of baseline).
  • Pentobarbital showed variable ACh changes, but a positive correlation existed between baseline ACh and its percentage change.

Conclusions:

  • Diverse anesthetics like halothane and ketamine, and likely pentobarbital, converge to increase ACh output from the IPN.
  • This suggests a common mechanism where anesthetics enhance the output of the IPN, a critical brainstem nucleus.

Related Concept Videos

Direct-Acting Cholinergic Agonists: Pharmacokinetics01:31

Direct-Acting Cholinergic Agonists: Pharmacokinetics

Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Neuromuscular Junction And Blockade01:29

Neuromuscular Junction And Blockade

The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...